Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02378220 · ClinicalTrials.gov registry record · NA
Pharmacogenetic Testing Among Home Health Patients
A NA study, sponsored by Genelex Corporation.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT02378220 is a NA study that has completed, run by Genelex Corporation. The registered enrollment target is 110 participants.
The verdict
NCT02378220, a NA study, has completed, sponsored by Genelex Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
Patients meeting eligibility criteria will be randomized into two groups, one receiving pharmacogenetic testing and the other not receiving pharmacogenetic testing. In this open-label trial, a pharmacist will make medication therapy recommendations using YouScript® Personalized Prescribing System for patients who receive genetic testing and standard drug information resources per usual for patients who do not undergo pharmacogenetic testing.
Interventions
- GENETIC Pharmacogenetic testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02378220
The ClinicalTrials.gov registry entry for NCT02378220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Genelex Corporation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pharmacogenetic testing is the first listed.
NCT02378220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02378220 about?
NCT02378220 is a clinical study titled "Pharmacogenetic Testing Among Home Health Patients". Patients meeting eligibility criteria will be randomized into two groups, one receiving pharmacogenetic testing and the other not receiving pharmacogenetic testing. In this open-label trial, a pharmacist will make medication therapy recommendations using YouScript® Personalized Prescribing System fo...
What is the current status of trial NCT02378220?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2015-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02378220?
The interventions under investigation include: Pharmacogenetic testing (GENETIC).
Who is sponsoring clinical trial NCT02378220?
This trial is sponsored by Genelex Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.